Company profile
BellRock Brands Inc.
OTC: DXBRF · Healthcare · Drug Manufacturers - Specialty & Generic
#617 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 35
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ market scale, return on assets
Methodology →Revenue TTM
$13.1M
Rev growth YoY (TTM)
+41.4%
Net income (FY)
-$20.1M
Employees
91
as of 2026-08-28
Market cap
$53.2k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$11.1M$11.1M2019
Net income-$20.1M-$20.1M2019
Operating income-$18.7M-$18.7M2019
Total assets$9.7M$9.7M2019
Liabilities$13.9M$13.9M2019
Equity-$2.6M-$2.6M2019
Revenue trend
FY2016 – FY2019 · USD
FY16
FY17
FY18
FY19
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is BellRock Brands Inc.’s revenue?
BellRock Brands Inc. booked $11.1M in FY2019 revenue, growing 92% year over year — faster than most Healthcare companies we track, at a -181.5% net margin.
Peers · Healthcare
Jaguar Health, Inc.38DNEXGEL, Inc.51DCaribou Biosciences, Inc.43DGSRX Industries Inc.——Veri Medtech Holdings Inc.46DOntrak, Inc.——Neighbors
Denver →Key facts
CEOSat Joshi
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersDenver, CO
ExchangeOTC: DXBRF
Employees91
IPO date2020-11-10
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.